Recent

% | $
Quotes you view appear here for quick access.

Muscle Pharm Corp. Message Board

  • fit4life_odell fit4life_odell Jul 22, 2010 12:13 PM Flag

    MSLP, Initial Evidence on Utilization of (RE-CON)

    MSLP

    DENVER--(BUSINESS WIRE)--MusclePharm® Corporation (OTCBB:MSLP - News), a fast-growing nutritional supplement company with a proprietary formulation used in eight performance products, today announced that the Company has been invited by The National Association of People with AIDS (NAPWA) to present at its non-commercial satellite symposium: Research Advances from Therapeutic Vaccines and Other Based Therapies Community Forum on July 22, 2010 at the XVIII International AIDS Conference in Vienna, Austria.

    “We are pleased that the NAPWA has invited us to participate in this important conference. We have a strong scientific research & development team that utilizes a scientific six-step program to make sure that our products are safe and effective,” commented Brad Pyatt, CEO of MusclePharm Corporation. “To be part of this conference is an important endorsement of our business model and product development process,” continued Brad Pyatt.

    Mariel Selbovitz, MPH will be presenting on behalf of MusclePharm on emerging evidence that the Company’s RE-CON product has shown clinical attributes that dramatically address the involuntary weight loss and catabolic cachexia in HIV patients on HAART (highly active antiretroviral therapy). These patients are at risk for the pathogenesis, transmigration and proliferation of resistant profiles of minority subspecies, provoking increased ratios of adverse proinflammatory cytokine ratios that are inversely correlated, as afforded by peer-reviewed literature, with a clear etiological pathway of morbid disease progression.

    Catabolic cachexia, also known as AIDS related wasting syndrome, has historically been a leading cause of characteristic disease progression in AIDS patients. Cachexia is difficult to treat and typical interventions do not consistently translate to sustainable clinical benefits. Additionally, prophylactic therapeutic nutritional supplementation has been identified as one of the most cost effective interventions to prevent predictable related disease progression.



    About MusclePharm Corporation

    MusclePharm’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside™. Headquartered in Denver, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere. To date, the company has developed eight products: ASSAULT®, BATTLE FUEL®, BULLET PROOF®, COMBAT POWDER®, RECON®, SHRED MATRIX®, and MUSCLEGEL®. Two additional products are due in stores in 2010.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
MSLP
4.14+0.09(+2.22%)Apr 17 3:59 PMEDT